February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
An overview of ICIs as a new treatment for hepatocellular carcinoma
Jan 7, 2025, 14:51

An overview of ICIs as a new treatment for hepatocellular carcinoma

Linda Qu, Assistant Editor at Tech Science Press, shared a recent article by Xuan-Yu Gu on LinkedIn:

Review Article Series: Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects.

This review provides an overview of ICIs as a new treatment for HCC, demonstrating some success in promoting the tumor immune response. 

However, drug resistance and adverse reactions remain important considerations that must be addressed. 

As tailored treatment plans evolve, the prospect of immunotherapy for HCC is expected to grow, offering new opportunities for improved patient outcomes.”

Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects

Authors: Xuan-Yu Gu, Jin-Long Huo, Zhi-Yong Yu, Ji-Chang Jiang, Ya-Xuan Xu and Li-Jin Zhao

hepatocellular carcinoma

For more updates, follow OncoDaily.